Inositol pyrophosphates, and methods of use thereof
The present invention comprises compounds, compositions thereof, and methods capable of delivering modified inositol hexaphospahte (IHP) comprising an internal pyrophosphate ring to the cytoplasm of mammalian cells. In certain embodiments, the present invention relates to compounds, compositions thereof, and methods that enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells.
1. A method of treating a mammal undergoing radiation therapy of cancer, comprising administering to the mammal a therapeutically effective amount of a composition comprising a compound represented by Formula I:
nC ⊕ A n⊖ I
wherein:
C + represents independently for each occurrence an aliphatic ammonium cation, an alkali metal cation, an alkaline earth cation, or other suitable metal cation;
A n− represents an inositol hexaphosphate comprising 1, 2, or 3 internal pyrophosphate rings or an acyl group; and
n is an integer in the range of 1 to 10 inclusive.
2. The method of claim 1 , wherein the inositol hexaphosphate comprises two internal pyrophosphate rings.
3. The method of claim 1 , wherein the inositol hexaphosphate comprises three internal pyrophosphate rings.
4. The method of claim 1 , wherein the aliphatic ammonium cation is a lipophilic, water-soluble aliphatic ammonium cation.
5. The method of claim 1 , wherein the aliphatic ammonium cation is a monoalkyl, dialkyl, trialkyl, or tetralkyl ammonium moiety.
6. The method of claim 1 , wherein the aliphatic ammonium cation is an N,N-dimethylcyclohexylammonium cation.
7. The method of claim 1 , wherein the aliphatic ammonium cation is a monoalkyl ammonium cation.
8. The method of claim 1 , wherein the aliphatic ammonium cation is a primary ammonium cation.
9. The method of claim 1 , wherein A is represented by the compound of the structure:
10. The method of claim 9 , wherein C is sodium and n is 6.
11. The method of claim 1 , wherein the compound is administered orally.
12. A method of treating a mammal undergoing radiation therapy of cancer, comprising administering to the mammal a therapeutically effective amount of a composition comprising a compound represented by Formula I:
nC ⊕ A n⊖ I
wherein:
C + represents independently for each occurrence an aliphatic ammonium cation, an alkali metal cation, an alkaline earth cation, or other suitable metal cation; and
A is represented by the compound of the structure:
and
n is an integer in the range of 1 to 10 inclusive.